Cargando…
Publisher Correction: Chimeric peptide EP45 as a dual agonist at GLP-1 and NPY2R receptors
Autores principales: | Chepurny, Oleg G., Bonaccorso, Ron L., Leech, Colin A., Wöllert, Torsten, Langford, George M., Schwede, Frank, Roth, Christian L., Doyle, Robert P., Holz, George G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899092/ https://www.ncbi.nlm.nih.gov/pubmed/29654321 http://dx.doi.org/10.1038/s41598-018-24359-2 |
Ejemplares similares
-
Chimeric peptide EP45 as a dual agonist at GLP-1 and NPY2R receptors
por: Chepurny, Oleg G., et al.
Publicado: (2018) -
Design and Evaluation of Peptide Dual-Agonists of
GLP-1 and NPY2 Receptors for Glucoregulation and Weight Loss
with Mitigated Nausea and Emesis
por: Milliken, Brandon T., et al.
Publicado: (2021) -
Intra-islet glucagon confers β-cell glucose competence for first-phase insulin secretion and favors GLP-1R stimulation by exogenous glucagon
por: Cabrera, Over, et al.
Publicado: (2021) -
Epac2A Makes a New Impact in β-Cell Biology
por: Holz, George G., et al.
Publicado: (2013) -
Leptin-stimulated K(ATP) channel trafficking: A new paradigm for β-cell stimulus-secretion coupling?
por: Holz, George G, et al.
Publicado: (2013)